Literature DB >> 15195974

A short alpha-helical antimicrobial peptide with antibacterial selectivity.

Song Yub Shin1, Kyung-Soo Hahm.   

Abstract

A 13-residue alpha-helical peptide (K6L5WP), designed from Leu6-->Pro substitution of a hemolytic alpha-helical peptide (K6L6W), exhibited strong antibacterial activity (MIC: 2 to approximately 4 microM against three gram-positives and three gram-negatives) comparable to that of melittin but had no hemolytic activity. Tryptophan fluorescence studies indicated bacterial selectivity of K6L5WP is closely related to the selective interaction with negatively charged phospholipids on the surface of bacterial cells. These results suggested that the central Pro6 in K6L5WP plays an important role in its bacterial cell selectivity. In conclusion, K6L5WP with antibacterial selectivity may serve as an attractive candidate for the development of antimicrobial agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195974     DOI: 10.1023/b:bile.0000024098.83025.de

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  3 in total

1.  Selective membrane disruption: mode of action of C16G2, a specifically targeted antimicrobial peptide.

Authors:  Christopher W Kaplan; Jee Hyun Sim; Kevin R Shah; Aida Kolesnikova-Kaplan; Wenyuan Shi; Randal Eckert
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Rational design of α-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as design parameters to improve the therapeutic ratio.

Authors:  Ziqing Jiang; Adriana I Vasil; Lajos Gera; Michael L Vasil; Robert S Hodges
Journal:  Chem Biol Drug Des       Date:  2011-02-02       Impact factor: 2.817

3.  "Specificity Determinants" Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 Against the Gram-negative Pathogens Acinetobacter baumannii and Pseudomonas aeruginosa.

Authors:  Ziqing Jiang; Adriana I Vasil; Michael L Vasil; Robert S Hodges
Journal:  Pharmaceuticals (Basel)       Date:  2014-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.